Jagsonpal Pharmaceuticals Ltd.
| BSE: 507789 | Sector: Health care |
| NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
| BSE 10:31 | 28 Sep | 167.05 |
17.35 (11.59%) |
OPEN
152.30 |
HIGH
171.00 |
LOW
152.25 |
| NSE 10:24 | 28 Sep | 168.80 |
19.25 (12.87%) |
OPEN
150.40 |
HIGH
172.40 |
LOW
150.40 |
| OPEN | 152.30 |
| PREVIOUS CLOSE | 149.70 |
| VOLUME | 27966 |
| 52-Week high | 203.25 |
| 52-Week low | 35.45 |
| P/E | 20.47 |
| Mkt Cap.(Rs cr) | 438 |
| Buy Price | 167.05 |
| Buy Qty | 94.00 |
| Sell Price | 167.15 |
| Sell Qty | 350.00 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 720.75 | -1.40 | -0.19 | 3112.91 |
| Cipla | 955.65 | -6.70 | -0.70 | 2468.28 |
| Dr Reddy's Labs | 4762.00 | -26.75 | -0.56 | 2186.40 |
| Sun Pharma.Inds. | 760.00 | -2.95 | -0.39 | 2139.70 |
| Divi's Lab. | 4874.90 | -58.60 | -1.19 | 1954.72 |
| Alkem Lab | 3952.20 | -48.45 | -1.21 | 1685.08 |
| Glenmark Pharma. | 498.80 | -4.95 | -0.98 | 1649.45 |
| Cadila Health. | 542.30 | -14.80 | -2.66 | 1476.20 |
| Lupin | 936.60 | 0.25 | 0.03 | 1258.62 |
| Alembic Pharma | 795.85 | 7.20 | 0.91 | 1175.39 |
| Ipca Labs. | 2364.00 | -8.35 | -0.35 | 1140.77 |
| Torrent Pharma. | 3057.25 | -31.85 | -1.03 | 1137.85 |
| Gland Pharma | 3847.30 | 2.10 | 0.05 | 997.01 |
| Laurus Labs | 595.55 | -4.20 | -0.70 | 956.11 |
| Abbott India | 21318.55 | 139.90 | 0.66 | 690.69 |
| Ajanta Pharma | 2222.85 | 44.50 | 2.04 | 675.64 |
| Wockhardt | 438.70 | -6.90 | -1.55 | 593.29 |
| Granules India | 320.25 | 1.15 | 0.36 | 552.78 |
| Pfizer | 5661.30 | 20.60 | 0.37 | 497.61 |
| Sanofi India | 7893.05 | -57.35 | -0.72 | 477.60 |
Quick Links for Jagsonpal Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
